In Vivo Experience With NRT to Increase Adherence and Smoking Abstinence

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

517 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2022-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a study to determine the efficacy of a smoking cessation intervention (nicotine replacement therapy (NRT) and counseling) done in a systematized manner with participants recruited from the UAB Substance Abuse Program. The definition of In Vivo experience is: use of the NRT medication during the session using specialized counseling focused around their experience of using NRT, including how the use of NRT may help them quit smoking, side effects, and smoking cessation expectancies. In this study those in the In Vivo group will put the patch on during Session 1 and given nicotine gum in Session 2 and will discuss the experience of wearing the patch or chewing the gum while they are in session. The control group will not put on the patch or chew gum during the sessions but will be given standard counseling regarding quitting smoking.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

NCT02162849

Tobacco Use Cessation

ACTIVE_NOT_RECRUITING PHASE4

Real-time eCounselling for Nicotine Addiction

NCT06544057

Nicotine Use Disorder

RECRUITING NA

Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes

NCT00622752

Smoking Cessation

COMPLETED PHASE2

A Pilot Study Evaluating Nicotine Lozenges and Self Help

NCT00888459

Smokeless Tobacco Use

COMPLETED PHASE2

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

NCT00301145

Unspecified Adult Solid Tumor, Protocol Specific

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim 1: Compare the efficacy of an In Vivo experiential intervention to a standard treatment control group for smoking cessation. The goal of this aim will be to compare the rates of point prevalence abstinence at the 6 month post-intervention follow-up. It is expected that smokers who receive the behavioral experience of the NRT In Vivo intervention will have higher rates of abstinence at the 6 month follow-up compared to the control group. Aim 2: Compare medication adherence between groups over the 12 week intervention. The goal of this aim is to determine the impact of the In Vivo behavioral experience intervention on promoting medication adherence to NRT. It is expected that individuals in the In Vivo NRT group will have better medication adherence relative to control participants. Exploratory: Examine moderators and mediators of the experimental intervention on smoking abstinence. The goal of this aim is to explore whether demographic and smoking characteristics (e.g., sex, race, nicotine dependence, motivational status, legal charges) moderate the effect of treatment on abstinence after 12 weeks of treatment and 6-month follow-up. In addition, we will look at changes in expectancies about NRT, medication adherence, and withdrawal symptoms to determine if these changes mediate the relationship between the experimental intervention and smoking abstinence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Reduction or Abstinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

In vivo group

Those who receive in vivo counseling and Nicotine Replacement Therapy (NRT)

Group Type EXPERIMENTAL

In vivo counseling

Intervention Type BEHAVIORAL

Participants in the intervention group will receive 4 in session nicotine replacement therapy and counseling focused on their experience of using NRT, including positive experiences, side effects and smoking cessation expectancies. They will also received nicotine replacement therapy (nicotine lozenge and patch) to use for smoking cessation.

Controls

Standard smoking cessation counseling and Nicotine Replacement Therapy (NRT)

Group Type ACTIVE_COMPARATOR

Standard Smoking Cessation Counseling

Intervention Type BEHAVIORAL

Participants will receive 4 sessions of standard behavioral counseling to address their smoking. In addition, participants will received nicotine replacement therapy (Nicotine lozenge and patch) to use for smoking cessation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In vivo counseling

Participants in the intervention group will receive 4 in session nicotine replacement therapy and counseling focused on their experience of using NRT, including positive experiences, side effects and smoking cessation expectancies. They will also received nicotine replacement therapy (nicotine lozenge and patch) to use for smoking cessation.

Intervention Type BEHAVIORAL

Standard Smoking Cessation Counseling

Participants will receive 4 sessions of standard behavioral counseling to address their smoking. In addition, participants will received nicotine replacement therapy (Nicotine lozenge and patch) to use for smoking cessation.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age,
* Under criminal justice supervision and expecting to remain under supervision for 9 months,
* Smoked at least 5 cigarettes per day for the last 12 months,
* Expire carbon dioxide (CO)\> 10 ppm.
* Must be able to read and speak English.
* Women of child-bearing potential must be using adequate birth control.

Exclusion Criteria

* Pregnant or breastfeeding women,
* Non-English speaking,
* Living in an restricted environment that does not allow smoking,
* Known sensitivity to nicotine replacement or allergy to adhesive used in nicotine patches,
* Cognitive impairment or major untreated mental illness that interferes with the informed consent process,
* Within 6 months post-myocardial infarction or untreated severe angina,
* Latex allergy,
* Daily or exclusive use of other tobacco products (e.g. cigars, e-cigarettes).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No